These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 14585249)
1. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249 [TBL] [Abstract][Full Text] [Related]
2. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization. Frøbert O; Hjortshøj SP; Simonsen U; Ravkilde J Int J Cardiol; 2008 Sep; 129(2):288-91. PubMed ID: 17689741 [TBL] [Abstract][Full Text] [Related]
3. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. Sen N; Ozlu MF; Akgul EO; Kanat S; Cayci T; Turak O; Yaman H; Sokmen E; Ozcan F; Maden O; Demir AD; Covic A; Kanbay M Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864 [TBL] [Abstract][Full Text] [Related]
4. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography. Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936 [TBL] [Abstract][Full Text] [Related]
5. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease. Lu TM; Ding YA; Charng MJ; Lin SJ Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916 [TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data. Maas R; Schulze F; Baumert J; Löwel H; Hamraz K; Schwedhelm E; Koenig W; Böger RH Clin Chem; 2007 Apr; 53(4):693-701. PubMed ID: 17317881 [TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791 [TBL] [Abstract][Full Text] [Related]
8. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644 [TBL] [Abstract][Full Text] [Related]
10. Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA. Ajtay Z; Scalera F; Cziráki A; Horváth I; Papp L; Sulyok E; Szabo C; Martens-Lobenhoffer J; Awiszus F; Bode-Böger SM Int J Mol Med; 2009 May; 23(5):651-7. PubMed ID: 19360324 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X. Lu TM; Lee TS; Lin SJ; Chan WL; Hsu CP PLoS One; 2017; 12(12):e0188995. PubMed ID: 29206850 [TBL] [Abstract][Full Text] [Related]
12. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention. Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695 [TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842 [TBL] [Abstract][Full Text] [Related]
15. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. Krempl TK; Maas R; Sydow K; Meinertz T; Böger RH; Kähler J Eur Heart J; 2005 Sep; 26(18):1846-51. PubMed ID: 15860520 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina. Surdacki A; Marewicz E; Wieczorek-Surdacka E; Rakowski T; Szastak G; Pryjma J; Dudek D; Dubiel JS Nephrol Dial Transplant; 2010 Aug; 25(8):2576-83. PubMed ID: 19729464 [TBL] [Abstract][Full Text] [Related]
17. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598 [TBL] [Abstract][Full Text] [Related]